About Index Trending news
Analyze
Top 50 Pricing
Trevi Therapeutics

Trevi Therapeutics

Work at Trevi Therapeutics? Add yourself to this profile

Trevi Therapeutics

Trevi Therapeutics is a drug development company founded in 2011 focused on developing Nalbuphine ER for the severe chronic itching condition known as pruritus.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Debt financing
$15,000,000
Square 1 Bank, Solar capital
Venture capital (Series B)
$26,000,000
TPG Biotech
Employees

Team size

2
Locations
HQ
Headquarters
$15,000,000 Debt financing
abladvisor

Solar Capital, Square 1 Bank Provide $15MM Facility to Trevi Therapeutics - News | ABL Advisor